Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Sutton

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Chromatography|October 23, 1992
Assay of timolol in human plasma using gas chromatography with electron-capture detectionB M Sutton, R A Richardson
The Annals of Pharmacotherapy|April 30, 1998
Systemic adverse effects associated with topically applied latanoprostA S Peak, B M Sutton
Advances in Colloid and Interface Science|November 1, 1987
Interfacial interactions between proteins and mammalian lipasesC J O'Connor, B M Sutton
The Journal of Organic Chemistry|June 27, 1975
Synthesis of fused phenothiazines. 2,3-dihydro-1H-pyrimido[5,6,1-Kl]phenothiazine-1,3-dione and 6H, 16H-[1,5]diazocino[3,2,1-kl:7,6,5-k'l']diphenothiazine-6,16-dioneJ Weinstock, D E Gaitanopoulos, B M Sutton
The New Zealand Medical Journal|April 22, 1987
The influence of proteins on the lipase activity of bile-salt-stimulated human milk lipaseJ O'Connor, P A Butler, B M Sutton
The Journal of Clinical Psychiatry|February 1, 1991
Long-term follow-up of chronic depression treated with imipramineJ H Kocsis, B M Sutton, A J Frances
Journal of Medicinal Chemistry|November 1, 1972
Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexesB M Sutton, E McGusty, D T Walz, et al.
Arzneimittel-Forschung|December 1, 1974
The effects of anti-arthritic gold compounds on mycoplasma and leishmaniaC E Berkoff, P Actor, B M Sutton, et al.
Journal of Medicinal Chemistry|January 1, 1974
Oral gold. Synthesis and antiarthritic properties of some large-ring gold chelatesJ Weinstock, B M Sutton, G Y Kuo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1976
Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162D T Walz, M J DiMartino, L W Chakrin, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Chromatography|October 23, 1992
Assay of timolol in human plasma using gas chromatography with electron-capture detectionB M Sutton, R A Richardson
The Annals of Pharmacotherapy|April 30, 1998
Systemic adverse effects associated with topically applied latanoprostA S Peak, B M Sutton
Advances in Colloid and Interface Science|November 1, 1987
Interfacial interactions between proteins and mammalian lipasesC J O'Connor, B M Sutton
The Journal of Organic Chemistry|June 27, 1975
Synthesis of fused phenothiazines. 2,3-dihydro-1H-pyrimido[5,6,1-Kl]phenothiazine-1,3-dione and 6H, 16H-[1,5]diazocino[3,2,1-kl:7,6,5-k'l']diphenothiazine-6,16-dioneJ Weinstock, D E Gaitanopoulos, B M Sutton
The New Zealand Medical Journal|April 22, 1987
The influence of proteins on the lipase activity of bile-salt-stimulated human milk lipaseJ O'Connor, P A Butler, B M Sutton
The Journal of Clinical Psychiatry|February 1, 1991
Long-term follow-up of chronic depression treated with imipramineJ H Kocsis, B M Sutton, A J Frances
Journal of Medicinal Chemistry|November 1, 1972
Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexesB M Sutton, E McGusty, D T Walz, et al.
Arzneimittel-Forschung|December 1, 1974
The effects of anti-arthritic gold compounds on mycoplasma and leishmaniaC E Berkoff, P Actor, B M Sutton, et al.
Journal of Medicinal Chemistry|January 1, 1974
Oral gold. Synthesis and antiarthritic properties of some large-ring gold chelatesJ Weinstock, B M Sutton, G Y Kuo, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1976
Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162D T Walz, M J DiMartino, L W Chakrin, et al.
Pageof 3